TLR4 and obesity disorder: HFD did alter ileal 5-HT levels only in WT mice, indicating the presence of low-grade intestinal inflammation and impaired ileal neuromuscular function, further supporting the involvement of TLR4 signaling in obesity-associated small intestine dysmotility, consistent with previous reports [34,35].